Form 8-K - Current report:
SEC Accession No. 0001193125-24-275534
Filing Date
2024-12-11
Accepted
2024-12-11 16:05:17
Documents
13
Period of Report
2024-12-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d903989d8k.htm   iXBRL 8-K 59624
  Complete submission text file 0001193125-24-275534.txt   180449

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zyme-20241210.xsd EX-101.SCH 2516
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20241210_lab.xml EX-101.LAB 17205
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20241210_pre.xml EX-101.PRE 10793
15 EXTRACTED XBRL INSTANCE DOCUMENT d903989d8k_htm.xml XML 3595
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 241541552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)